GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Short Percentage of Float

Medy-Tox (XKRX:086900) Short Percentage of Float


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Medy-Tox's Short Percentage of Float

For the Biotechnology subindustry, Medy-Tox's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medy-Tox's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medy-Tox's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Medy-Tox's Short Percentage of Float falls into.



Medy-Tox (XKRX:086900) Business Description

Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines